{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:24:25Z","timestamp":1777602265997,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["PDF17483149"],"award-info":[{"award-number":["PDF17483149"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4778-7","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T12:29:31Z","timestamp":1535977771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3847-1225","authenticated-orcid":false,"given":"Amy A.","family":"Kirkham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Ian","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla M.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry S.","family":"Courneya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Pituskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"key":"4778_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003495-199700544-00003","volume":"54","author":"GN Hortobagyi","year":"1997","unstructured":"Hortobagyi GN. Anthracyclines in the treatment of cancer. Drugs. 1997;54:1\u20137.","journal-title":"Drugs"},{"key":"4778_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/1471-2407-10-337","volume":"10","author":"LA Smith","year":"2010","unstructured":"Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 2010;10:337.","journal-title":"BMC Cancer"},{"key":"4778_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1200\/JCO.2007.14.8742","volume":"26","author":"MS Ewer","year":"2008","unstructured":"Ewer MS, Lenihan DJ. Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground? J Clin Oncol. 2008;26:1201\u20133.","journal-title":"J Clin Oncol"},{"key":"4778_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56:185\u2013229.","journal-title":"Pharmacol Rev"},{"key":"4778_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","volume":"27","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27:911\u201339.","journal-title":"J Am Soc Echocardiogr"},{"key":"4778_CR6","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131:1981\u20138.","journal-title":"Circulation"},{"key":"4778_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1309\/AJCPB66LRIIVMQDR","volume":"130","author":"A Dolci","year":"2008","unstructured":"Dolci A, Dominici R, Cardinale D, Sandri MT, Panteghini M. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol. 2008;130:688\u201395.","journal-title":"Am J Clin Pathol"},{"key":"4778_CR8","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim K-D, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63:2751\u201368.","journal-title":"J Am Coll Cardiol"},{"key":"4778_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.hfc.2011.03.005","volume":"7","author":"RM Witteles","year":"2011","unstructured":"Witteles RM, Fowler MB, Telli ML. Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented? Heart Fail Clin. 2011;7:333\u201344.","journal-title":"Heart Fail Clin"},{"key":"4778_CR10","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1200\/JCO.2006.10.4976","volume":"25","author":"MC Pinder","year":"2007","unstructured":"Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol. 2007;25:3808\u201315.","journal-title":"J Clin Oncol"},{"key":"4778_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/annonc\/mdr160","volume":"23","author":"M Riihimaki","year":"2012","unstructured":"Riihimaki M, Thomsen H, Brandt A, Sundquist J, Hemminki K. Death causes in breast cancer patients. Ann Oncol. 2012;23:604\u201310.","journal-title":"Ann Oncol"},{"key":"4778_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-017-4282-9","volume":"164","author":"SAM Gernaat","year":"2017","unstructured":"Gernaat SAM, Ho PJ, Rijnberg N, Emaus MJ, Baak LM, Hartman M, et al. Risk of death from cardiovascular disease following breast cancer: a systematic review. Breast Cancer Res Treat. 2017;164:537\u201355.","journal-title":"Breast Cancer Res Treat"},{"key":"4778_CR13","doi-asserted-by":"crossref","unstructured":"Chang J. Chemotherapy dose reduction and delay in clinical practice: Evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer. Eur J Cancer. 2000;36:11-14.","DOI":"10.1016\/S0959-8049(99)00259-2"},{"key":"4778_CR14","doi-asserted-by":"crossref","unstructured":"Kaya MG, Ozkan M, Gunebakmaz O, Akkaya H, Kaya EG, Akpek M, et al. Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study. Int J Cardiol. 2013;167:2306\u201310.","DOI":"10.1016\/j.ijcard.2012.06.023"},{"key":"4778_CR15","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","volume":"48","author":"N Kalay","year":"2006","unstructured":"Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol. 2006;48:2258\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"4778_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/ajh.21840","volume":"85","author":"P Georgakopoulos","year":"2010","unstructured":"Georgakopoulos P, Roussou P, Matsakas E, Karavidas A, Anagnostopoulos N, Marinakis T, et al. Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up. Am J Hematol. 2010;85:894\u20136.","journal-title":"Am J Hematol"},{"key":"4778_CR17","doi-asserted-by":"crossref","unstructured":"Kirkham AA, Davis MK: Exercise prevention of cardiovascular disease in breast cancer survivors. J Oncol. 2015;Article ID 917606.","DOI":"10.1155\/2015\/917606"},{"key":"4778_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1249\/MSS.0000000000001446","volume":"50","author":"AA Kirkham","year":"2018","unstructured":"Kirkham AA, Bonsignore A, Bland KA, McKenzie DC, Gelmon KA, Van Patten CL, Campbell KL. Exercise prescription and adherence for breast cancer: one size does not FITT all. Med Sci Sports Exerc. 2018;50:177\u201386.","journal-title":"Med Sci Sports Exerc"},{"key":"4778_CR19","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.4161\/cc.9.22.13954","volume":"9","author":"L Raffaghello","year":"2014","unstructured":"Raffaghello L, Safdie F, Bianchi G, Dorff T, Fontana L, Longo VD. Fasting and differential chemotherapy protection in patients. Cell Cycle. 2014;9:4474\u20136.","journal-title":"Cell Cycle"},{"key":"4778_CR20","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.1073\/pnas.0708100105","volume":"105","author":"L Raffaghello","year":"2008","unstructured":"Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U S A. 2008;105:8215\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4778_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.taap.2007.07.018","volume":"225","author":"MS Mitra","year":"2007","unstructured":"Mitra MS, Donthamsetty S, White B, Latendresse JR, Mehendale HM. Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity. Toxicol Appl Pharmacolo. 2007;225:90\u2013101.","journal-title":"Toxicol Appl Pharmacolo"},{"key":"4778_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4331\/wjbc.v5.i3.269","volume":"5","author":"AJ Dirks-Naylor","year":"2014","unstructured":"Dirks-Naylor AJ, Kouzi SA, Yang S. Can short-term fasting protect against doxorubicin-induced cardiotoxicity? World J Biol Chem. 2014;5:269\u201374.","journal-title":"World J Biol Chem"},{"key":"4778_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/CS20100254","volume":"120","author":"A Ascens\u00e3o","year":"2011","unstructured":"Ascens\u00e3o A, Lumini Oliveira J, Machado NG, Ferreira RM, Gon\u00e7alves IO, Moreira AC, et al. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats. Clin Sci. 2011;120:37\u201349.","journal-title":"Clin Sci"},{"key":"4778_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1534735408322848","volume":"7","author":"KY Wonders","year":"2008","unstructured":"Wonders KY, Hydock DS, Schneider CM, Hayward R. Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther. 2008;7:147\u201354.","journal-title":"Integr Cancer Ther"},{"key":"4778_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2017.07.037","volume":"245","author":"AA Kirkham","year":"2017","unstructured":"Kirkham AA, Shave RE, Bland KA, Bovard JM, Eves ND, Gelmon KA, et al. Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: a proof-of-concept RCT. Int J Cardiol. 2017;245:263\u201370.","journal-title":"Int J Cardiol"},{"key":"4778_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10549-017-4554-4","volume":"167","author":"AA Kirkham","year":"2018","unstructured":"Kirkham AA, Eves ND, Shave RE, Bland KA, Bovard J, Gelmon KA, et al. The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT. Breast Cancer Res Treat. 2018;167:719\u201329.","journal-title":"Breast Cancer Res Treat"},{"key":"4778_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/cvr\/cvs282","volume":"96","author":"T Kawaguchi","year":"2012","unstructured":"Kawaguchi T, Takemura G, Kanamori H, Takeyama T, Watanabe T, Morishita K, et al. Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes. Cardiovasc Res. 2012;96:456\u201365.","journal-title":"Cardiovasc Res"},{"key":"4778_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12885-015-1663-5","volume":"15","author":"S de Groot","year":"2015","unstructured":"de Groot S, Vreeswijk MPG, Welters MJP, Gravesteijn G, Boei JJWA, Jochems A, et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. 2015;15:652.","journal-title":"BMC Cancer"},{"key":"4778_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s13105-012-0200-0","volume":"69","author":"R Hayward","year":"2013","unstructured":"Hayward R, Hydock D, Gibson N, Greufe S, Bredahl E, Parry T. Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function. J Physiol Biochem. 2013;69:177\u201387.","journal-title":"J Physiol Biochem"},{"key":"4778_CR30","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/S0735-1097(97)00381-1","volume":"30","author":"D Harrington","year":"1997","unstructured":"Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol. 1997;30:1758\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"4778_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","volume":"60","author":"CN Marti","year":"2012","unstructured":"Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol. 2012;60:1455\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"4778_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jnutbio.2005.11.002","volume":"17","author":"AJ Dirks","year":"2006","unstructured":"Dirks AJ, Leeuwenburgh C. Tumor necrosis factor \u03b1 signaling in skeletal muscle: effects of age and caloric restriction. J Nutr Biochem. 2006;17:501\u20138.","journal-title":"J Nutr Biochem"},{"key":"4778_CR33","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1152\/japplphysiol.00776.2009","volume":"107","author":"LAA Gilliam","year":"2009","unstructured":"Gilliam LAA, Ferreira LF, Bruton JD, Moylan JS, Westerblad H, St Clair DK, et al. Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle. J Appl Physiol. 2009;107:1935\u201342.","journal-title":"J Appl Physiol"},{"key":"4778_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2334\/josnusd.52.133","volume":"52","author":"ZA Rahman","year":"2010","unstructured":"Rahman ZA, Abdullah N, Singh R, Sosroseno W. Effect of acute exercise on the levels of salivary cortisol, tumor necrosis factor-alpha and nitric oxide. J Oral Sci. 2010;52:133\u20136.","journal-title":"J Oral Sci"},{"key":"4778_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jash.2009.10.005","volume":"4","author":"C Matsuura","year":"2010","unstructured":"Matsuura C, Brunini T, Carvalho LCMM, Resende AC, Carvalho JJ, de Castro JPW, et al. Exercise training in doxorubicin-induced heart failure: effects on the L-arginine\u2013NO pathway and vascular reactivity. J Am Soc Hypertens. 2010;4:7\u201313.","journal-title":"J Am Soc Hypertens"},{"key":"4778_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1474-9726.2010.00557.x","volume":"9","author":"C Rippe","year":"2010","unstructured":"Rippe C, Lesniewski L, Connell M, LaRocca T, Donato A, Seals D. Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell. 2010;9:304\u201312.","journal-title":"Aging Cell"},{"key":"4778_CR37","doi-asserted-by":"publisher","first-page":"djv040","DOI":"10.1093\/jnci\/djv040","volume":"107","author":"AS Betof","year":"2015","unstructured":"Betof AS, Lascola CD, Weitzel D, Landon C, Scarbrough PM, Devi GR, et al. Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. J Natl Cancer Inst. 2015;107:djv040.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl","key":"4778_CR38","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.bbi.2012.05.001","volume":"30","author":"AS Betof","year":"2013","unstructured":"Betof AS, Dewhirst MW, Jones LW. Effects and potential mechanisms of exercise training on cancer progression: a translational perspective. Brain Behav Immun. 2013;30(Suppl):S75\u201387.","journal-title":"Brain Behav Immun"},{"key":"4778_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/carcin\/bgp280","volume":"31","author":"SD Hursting","year":"2010","unstructured":"Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis. 2010;31:83\u20139.","journal-title":"Carcinogenesis"},{"key":"4778_CR40","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine. Identifier NCT. Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects (CREATE); 2017 Apr 27 [cited 2018 Jul 30]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03131024"},{"key":"4778_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/IJWH.S68745","volume":"7","author":"AA Kirkham","year":"2015","unstructured":"Kirkham AA, Virani SA, Campbell KL. The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review. Int J Womens Health. 2015;7:127\u201340.","journal-title":"Int J Womens Health"},{"key":"4778_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijcard.2005.07.029","volume":"111","author":"M Civelli","year":"2006","unstructured":"Civelli M, Cardinale D, Martinoni A, Lamantia G, Colombo N, Colombo A, et al. Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity. Int J Cardiol. 2006;111:120\u20136.","journal-title":"Int J Cardiol"},{"key":"4778_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/00130404-200511000-00004","volume":"11","author":"R Sawhney","year":"2005","unstructured":"Sawhney R, Sehl M, Naeim A. Physiologic aspects of aging: impact on cancer management and decision making, part I. Cancer J. 2005;11:449\u201360.","journal-title":"Cancer J"},{"key":"4778_CR44","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1200\/JCO.2012.44.0891","volume":"30","author":"GJ Koelwyn","year":"2012","unstructured":"Koelwyn GJ, Khouri M, Mackey JR, Douglas PS, Jones LW. Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship. J Clin Oncol. 2012;30:4458\u201361.","journal-title":"J Clin Oncol"},{"key":"4778_CR45","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1200\/JCO.2011.39.9014","volume":"30","author":"LW Jones","year":"2012","unstructured":"Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, et al. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol. 2012;30:2530\u20137.","journal-title":"J Clin Oncol"},{"key":"4778_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mrm.22177","volume":"63","author":"D Hernando","year":"2010","unstructured":"Hernando D, Kellman P, Haldar JP, Liang ZP. Robust water\/fat separation in the presence of large field inhomogeneities using a graph cut algorithm. Magn Reson Med. 2010;63:79\u201390.","journal-title":"Magn Reson Med"},{"key":"4778_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163513","volume":"11","author":"RB Thompson","year":"2016","unstructured":"Thompson RB, Pagano JJ, Mathewson KW, Paterson I, Dyck JR, Kitzman DW, et al. Differential responses of post-exercise recovery of leg blood flow and oxygen uptake kinetics in HFpEF versus HFrEF. PLoS One. 2016;11:e0163513.","journal-title":"PLoS One"},{"key":"4778_CR48","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/mrm.24878","volume":"71","author":"K Chow","year":"2013","unstructured":"Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB. Saturation recovery single-shot acquisition (SASHA) for myocardial T1mapping. Magn Reson Med. 2013;71:2082\u201395.","journal-title":"Magn Reson Med"},{"key":"4778_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mrm.20110","volume":"52","author":"DR Messroghli","year":"2004","unstructured":"Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified look-locker inversion recovery (MOLLI) for high-resolutionT1 mapping of the heart. Magn Reson Med. 2004;52:141\u20136.","journal-title":"Magn Reson Med"},{"key":"4778_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1161\/CIRCIMAGING.112.980037","volume":"6","author":"A La Gerche","year":"2013","unstructured":"La Gerche A, Claessen G, Van de Bruaene A, Pattyn N, Van Cleemput J, Gewillig M, et al. Cardiac MRI: a new gold standard for ventricular volume quantification during high-intensity exercise. Circ Cardiovasc Imaging. 2013;6:329\u201338.","journal-title":"Circ Cardiovasc Imaging"},{"key":"4778_CR51","volume-title":"ACSM's guidelines for exercise testing and prescription","year":"2014","unstructured":"Pescatello LS, Arena R, Riebe D, Thompson PD, editors. ACSM's guidelines for exercise testing and prescription. 9th ed. Philadelphia, PA: Wolters Kluwer Lippincott Williams & Wilkins; 2014.","edition":"9"},{"key":"4778_CR52","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/bjc.2011.439","volume":"105","author":"S Romano","year":"2011","unstructured":"Romano S, Fratini S, Ricevuto E, Procaccini V, Stifano G, Mancini M, et al. Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. Br J Cancer. 2011;105:1663\u20138.","journal-title":"Br J Cancer"},{"key":"4778_CR53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1743-7563.2012.01588.x","volume":"9","author":"A Kittiwarawut","year":"2012","unstructured":"Kittiwarawut A, Vorasettakarnkij Y, Tanasanvimon S, Manasnayakorn S, Sriuranpong V. Serum NT-proBNP in the early detection of doxorubicin-induced cardiac dysfunction. Asia-Pac J Clin Oncol. 2012;9:155\u201361.","journal-title":"Asia-Pac J Clin Oncol"},{"key":"4778_CR54","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","volume":"24","author":"D Cella","year":"2002","unstructured":"Cella D, Eton DT, Lai J-S, Peterman AH, Merkel DE. Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of Cancer therapy (FACT) anemia and fatigue scales. J Pain Symptom Manag. 2002;24:547\u201361.","journal-title":"J Pain Symptom Manag"},{"key":"4778_CR55","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0885-3924(03)00321-X","volume":"26","author":"KD Stein","year":"2003","unstructured":"Stein KD, Denniston M, Baker F, Dent M, Hann DM, Bushhouse S, et al. Validation of a modified Rotterdam symptom checklist for use with cancer patients in the United States. J Pain Symptom Manag. 2003;26:975\u201389.","journal-title":"J Pain Symptom Manag"},{"key":"4778_CR56","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/sj.ijo.0801656","volume":"25","author":"L de Jonge","year":"2001","unstructured":"de Jonge L, Nguyen T, Smith SR, Zachwieja JJ, Roy HJ, Bray GA. Prediction of energy expenditure in a whole body indirect calorimeter at both low and high levels of physical activity. Int J Obesity. 2001;25:929\u201334.","journal-title":"Int J Obesity"},{"key":"4778_CR57","volume-title":"Panel on micronutrients: dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids","author":"Institute of Medicine (US)","year":"2005","unstructured":"Institute of Medicine (US). Panel on micronutrients: dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. Bethesda, MD: Institute of Medicine; 2005."},{"key":"4778_CR58","first-page":"18","volume":"4","author":"G Godin","year":"2011","unstructured":"Godin G. The Godin-Shephard leisure-time physical activity questionnaire. Health Fit J Can. 2011;4:18\u201322.","journal-title":"Health Fit J Can"},{"key":"4778_CR59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3945\/ajcn.2009.28432","volume":"91","author":"H Besson","year":"2009","unstructured":"Besson H, Brage S, Jakes RW, Ekelund U, Wareham NJ. Estimating physical activity energy expenditure, sedentary time, and physical activity intensity by self-report in adults. Am J Clin Nutr. 2009;91:106\u201314.","journal-title":"Am J Clin Nutr"},{"key":"4778_CR60","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/10976640009148691","volume":"2","author":"NG Bellenger","year":"2000","unstructured":"Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2000;2:271\u20138.","journal-title":"J Cardiovasc Magn Reson"}],"updated-by":[{"DOI":"10.1186\/s12885-019-5298-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4778-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T22:07:12Z","timestamp":1720562832000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4778-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4778"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4778-7","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-019-5298-9","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"19 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CREATE study has been approved by the Health Research Ethics Board of Alberta \u2018Cancer Committee\u2019 (HREBA.CC-17-0129). All participants will provide written informed consent prior to participating in any study assessments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"864"}}